Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 2
2005 2
2006 3
2007 3
2008 1
2009 2
2010 2
2011 5
2012 10
2013 3
2014 3
2015 10
2016 7
2017 7
2018 7
2019 20
2020 14
2021 15
2022 7
2023 12
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

126 results

Results by year

Filters applied: . Clear all
Page 1
Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors.
Nuñez NG, Berner F, Friebel E, Unger S, Wyss N, Gomez JM, Purde MT, Niederer R, Porsch M, Lichtensteiger C, Kramer R, Erdmann M, Schmitt C, Heinzerling L, Abdou MT, Karbach J, Schadendorf D, Zimmer L, Ugurel S, Klümper N, Hölzel M, Power L, Kreutmair S, Capone M, Madonna G, Cevhertas L, Heider A, Amaral T, Hasan Ali O, Bomze D, Dimitriou F, Diem S, Ascierto PA, Dummer R, Jäger E, Driessen C, Levesque MP, van de Veen W, Joerger M, Früh M, Becher B, Flatz L. Nuñez NG, et al. Among authors: joerger m. Med. 2023 Feb 10;4(2):113-129.e7. doi: 10.1016/j.medj.2022.12.007. Epub 2023 Jan 23. Med. 2023. PMID: 36693381 Free article.
Non-pharmaceutical interventions to optimize cancer immunotherapy.
Boesch M, Baty F, Rassouli F, Kowatsch T, Joerger M, Früh M, Brutsche MH. Boesch M, et al. Among authors: joerger m. Oncoimmunology. 2023 Sep 28;12(1):2255459. doi: 10.1080/2162402X.2023.2255459. eCollection 2023. Oncoimmunology. 2023. PMID: 37791231 Free PMC article. Review.
SAKK 16/14: Durvalumab in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non-Small-Cell Lung Cancer-A Multicenter Single-Arm Phase II Trial.
Rothschild SI, Zippelius A, Eboulet EI, Savic Prince S, Betticher D, Bettini A, Früh M, Joerger M, Lardinois D, Gelpke H, Mauti LA, Britschgi C, Weder W, Peters S, Mark M, Cathomas R, Ochsenbein AF, Janthur WD, Waibel C, Mach N, Froesch P, Buess M, Bohanes P, Godar G, Rusterholz C, Gonzalez M, Pless M; Swiss Group for Clinical Cancer Research (SAKK). Rothschild SI, et al. Among authors: joerger m. J Clin Oncol. 2021 Sep 10;39(26):2872-2880. doi: 10.1200/JCO.21.00276. Epub 2021 Jul 12. J Clin Oncol. 2021. PMID: 34251873 Free article. Clinical Trial.
Phase I/Ib, open-label, multicenter, dose-escalation study of the anti-TGF-β monoclonal antibody, NIS793, in combination with spartalizumab in adult patients with advanced tumors.
Bauer TM, Santoro A, Lin CC, Garrido-Laguna I, Joerger M, Greil R, Spreafico A, Yau T, Goebeler ME, Hütter-Krönke ML, Perotti A, Juif PE, Lu D, Barys L, Cremasco V, Pelletier M, Evans H, Fabre C, Doi T. Bauer TM, et al. Among authors: joerger m. J Immunother Cancer. 2023 Nov 29;11(11):e007353. doi: 10.1136/jitc-2023-007353. J Immunother Cancer. 2023. PMID: 38030303 Free PMC article. Clinical Trial.
Radiotherapy for thymic epithelial tumours: a review.
Süveg K, Putora PM, Joerger M, Iseli T, Fischer GF, Ammann K, Glatzer M. Süveg K, et al. Among authors: joerger m. Transl Lung Cancer Res. 2021 Apr;10(4):2088-2100. doi: 10.21037/tlcr-20-458. Transl Lung Cancer Res. 2021. PMID: 34012817 Free PMC article. Review.
Metabolism of the taxanes including nab-paclitaxel.
Joerger M. Joerger M. Expert Opin Drug Metab Toxicol. 2015 May;11(5):691-702. doi: 10.1517/17425255.2015.983074. Epub 2014 Nov 14. Expert Opin Drug Metab Toxicol. 2015. PMID: 25394848 Review.
Gemcitabine-associated hemolytic-uremic syndrome.
Walter RB, Joerger M, Pestalozzi BC. Walter RB, et al. Among authors: joerger m. Am J Kidney Dis. 2002 Oct;40(4):E16. doi: 10.1053/ajkd.2002.35758. Am J Kidney Dis. 2002. PMID: 12324937 Review.
Tumour neoantigen mimicry by microbial species in cancer immunotherapy.
Boesch M, Baty F, Rothschild SI, Tamm M, Joerger M, Früh M, Brutsche MH. Boesch M, et al. Among authors: joerger m. Br J Cancer. 2021 Aug;125(3):313-323. doi: 10.1038/s41416-021-01365-2. Epub 2021 Apr 6. Br J Cancer. 2021. PMID: 33824481 Free PMC article. Review.
Treatment regimens of classical and newer taxanes.
Joerger M. Joerger M. Cancer Chemother Pharmacol. 2016 Feb;77(2):221-33. doi: 10.1007/s00280-015-2893-6. Epub 2015 Nov 20. Cancer Chemother Pharmacol. 2016. PMID: 26589792 Review.
126 results